Insys Therapeutics competitors

Insys Therapeutics's competitors include Depomed, Lava Therapeutics, Tetherex and Regeneron Pharmaceuticals
Add company...
Insys Therapeutics
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.
Depomed
Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.
Lava Therapeutics
Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.
Tetherex
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Founding Date
Founding Date
1998
Founding Date
1995
Founding Date
2016
Founding Date
2014
Founding Date
1988
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Chandler, US HQ
Round Rock, US
Chandler, US
Locations
Newark, US HQ
Locations
's-Hertogenbosch, NL HQ
Locations
Oklahoma City, US HQ
Morrisville, US
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Rensselaer, US
Basking Ridge, US
Employees
Employees
423
Employees
490
Employees
4
Employees
N/A
Employees
6,20015% increase
Valuation ($)
Valuation ($)
597.9 m
Valuation ($)
443.2 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
34 b

Financial

Revenue (est.)
Revenue (est.)
$140.7m (FY, 2017)
Revenue (est.)
$380.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$4.9b (FY, 2016)
Cost of goods
Cost of goods
$20.6m (FY, 2017)
Cost of goods
$72.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$194.6m (FY, 2016)
Gross profit
Gross profit
$120.1m (FY, 2017)
Gross profit
$308.1m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$4.7b (FY, 2016)
Net income
Net income
($228m) (FY, 2017)
Net income
($102.5m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
$895.5m (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 18.7m (27 days ago)
Latest funding round
$ 43m (4 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 2.3m
Total funding raised
$ 875m
Total funding raised
$ 18.7m
Total funding raised
$ 46.2m
Total funding raised
$ 8.9m
For sources of this data, please see the company profileDownload Excel

View company profiles

Depomed
HQ
Newark, US
Employees
490

Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.

View company
Lava Therapeutics
HQ
's-Hertogenbosch, NL
Employees
4

Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.

View company
Tetherex
HQ
Oklahoma City, US

Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
6,200↑ 15% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

View company